Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
A. S. Garcia-Gomes, J. A. R. Curvelo, R. M. A Soares & A. Ferreira-Pereira. (2012) Curcumin acts synergistically with fluconazole to sensitize a clinical isolate of Candida albicans showing a MDR phenotype. Medical Mycology 50:1, pages 26-32.
Read now
Read now
Alan J. Fischman, Nathaniel M. Alpert, John W. Babich & Robert H. Rubin. (1997) The Role of Positron Emission Tomography in Pharmacokinetic Analysis. Drug Metabolism Reviews 29:4, pages 923-956.
Read now
Read now
Articles from other publishers (20)
Andreia Bento-Oliveira, Maria-Luísa C.J. Moita, Rodrigo F.M. de Almeida & Radosław Starosta. (2024) Unraveling environmental effects in the absorption and fluorescence spectra of p-methoxyphenylpiperazine derivatives. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 306, pages 123583.
Crossref
Crossref
Wanying Wu, Tianqing Jiang, Haihui Lin, Chao Chen, Lingling Wang, Jikai Wen, Jun Wu & Yiqun Deng. (2023) The Specific Binding and Promotion Effect of Azoles on Human Aldo-Keto Reductase 7A2. Metabolites 13:5, pages 601.
Crossref
Crossref
Jack D Sobel. (2023) New Antifungals for Vulvovaginal Candidiasis: What Is Their Role?. Clinical Infectious Diseases 76:5, pages 783-785.
Crossref
Crossref
Pranay Wal, Nikita Saraswat & Himangi Vig. (2022) A Detailed Insight onto the Molecular and Cellular Mechanism of Action
of the Antifungal Drugs Used in the Treatment of Superficial Fungal
Infections. Current Drug Therapy 17:3, pages 148-159.
Crossref
Crossref
Mohammad Shafiei, Lee Peyton, Mehrnoosh Hashemzadeh & Alireza Foroumadi. (2020) History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action. Bioorganic Chemistry 104, pages 104240.
Crossref
Crossref
Cristina de Castro Spadari, Fernanda Wirth, Luciana Biagini Lopes & Kelly Ishida. (2020) New Approaches for Cryptococcosis Treatment. Microorganisms 8:4, pages 613.
Crossref
Crossref
Felix Bongomin, Rita O. Oladele, Sara Gago, Caroline B. Moore & Malcolm D. Richardson. (2018)
A systematic review of fluconazole resistance in clinical isolates of
Cryptococcus
species
. Mycoses 61:5, pages 290-297.
Crossref
Crossref
Nermin H. Ibrahim, Nahla A. Melake, Ali M. Somily, Azza S. Zakaria, Manal M. Baddour & Amany Z. Mahmoud. (2015) The effect of antifungal combination on transcripts of a subset of drug-resistance genes in clinical isolates of Candida species induced biofilms. Saudi Pharmaceutical Journal 23:1, pages 55-66.
Crossref
Crossref
Heleen Nailis, Davy Vandenbosch, Dieter Deforce, Hans J. Nelis & Tom Coenye. (2010) Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms. Research in Microbiology 161:4, pages 284-292.
Crossref
Crossref
Sheng-Yuan Ruan & Po-Ren Hsueh. (2009) Invasive Candidiasis: An Overview from Taiwan. Journal of the Formosan Medical Association 108:6, pages 443-451.
Crossref
Crossref
Yong Cui & Erica Yao. (2008) Evaluation of Hydrate-Screening Methods. Journal of Pharmaceutical Sciences 97:7, pages 2730-2744.
Crossref
Crossref
C. Charlier, E. Hart, A. Lefort, P. Ribaud, F. Dromer, D. W. Denning & O. Lortholary. (2006) Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?. Journal of Antimicrobial Chemotherapy 57:3, pages 384-410.
Crossref
Crossref
Arthur Bentley, Michael Butters, Stuart P. Green, William J. Learmonth, Julie A. MacRae, Matthew C. Morland, Garry O'Conno & Joanne Skuse. (2002) The Discovery and Process Development of a Commercial Route to the Water Soluble Prodrug, Fosfluconazole. Organic Process Research & Development 6:2, pages 109-112.
Crossref
Crossref
Alan J. Fischman, Nathaniel M. Alpert & Robert H. Rubin. (2002) Pharmacokinetic Imaging. Clinical Pharmacokinetics 41:8, pages 581-602.
Crossref
Crossref
Eric O Aboagye, Patricia M Price & Terry Jones. (2001) In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography. Drug Discovery Today 6:6, pages 293-302.
Crossref
Crossref
Azeem Saleem, Eric O Aboagye & Patricia M Price. (2000) In vivo monitoring of drugs using radiotracer techniques. Advanced Drug Delivery Reviews 41:1, pages 21-39.
Crossref
Crossref
Richard J. Hammes & John W. Babich. (2016) Positron Emission Tomography: Clinical Applications and Pharmaceutical Care. Journal of Pharmacy Practice 7:3, pages 124-139.
Crossref
Crossref
A J FischmanN M AlpertE LivniS RayI SinclairR J CallahanJ A CorreiaD WebbH W StraussR H Rubin. (1993) Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrobial Agents and Chemotherapy 37:6, pages 1270-1277.
Crossref
Crossref
James W. Lee, Nita L. Seibel, Michael Amantea, Patricia Whitcomb, Philip A. Pizzo & Thomas J. Walsh. (1992) Safety and pharmacokinetics of fluconazole in children with neoplastic diseases. The Journal of Pediatrics 120:6, pages 987-993.
Crossref
Crossref
E. Livni, Alan J. Fischman, Stephen Ray, Ian Sinclair, David R. Elmaleh, Nathaniel M. Alpert, Stephen Weiss, John A. Correia, Douglas Webb, Robert Dahl, William Robeson, Donald Margouleff, Robert Liss, H.William Strauss & Robert H. Rubin. (1992) Synthesis of 18F-labeled fluconazole and positron emission tomography studies in rabbits. International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology 19:2, pages 191-199.
Crossref
Crossref